{{Rsnum
|rsid=572515
|Gene=CFH
|Chromosome=1
|position=196677131
|Orientation=minus
|GMAF=0.2342
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CFH
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 38.1 | 49.6 | 12.4
| HCB | 84.0 | 14.5 | 1.5
| JPT | 89.8 | 8.3 | 1.9
| YRI | 67.6 | 30.3 | 2.1
| ASW | 71.4 | 17.9 | 10.7
| CHB | 84.0 | 14.5 | 1.5
| CHD | 95.4 | 4.6 | 0.0
| GIH | 46.0 | 42.0 | 12.0
| LWK | 65.7 | 32.4 | 1.9
| MEX | 53.6 | 37.5 | 8.9
| MKK | 61.7 | 33.1 | 5.2
| TSI | 50.0 | 32.4 | 17.6
| HapMapRevision=28
}}

{{PMID|18541031|OA=1
}} [[rs572515]] was the most significantly associated of a group of SNPs in the chromosome 1q32-33 region with risk for neovascular [[age related macular degeneration]] (p < 10-6).

{{PMID Auto
|PMID=20385826
|Title=Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}